Does DAUNORUBICIN Cause Hyperkeratosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hyperkeratosis have been filed in association with DAUNORUBICIN (Daunorubicin Hydrochloride). This represents 0.1% of all adverse event reports for DAUNORUBICIN.
5
Reports of Hyperkeratosis with DAUNORUBICIN
0.1%
of all DAUNORUBICIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hyperkeratosis From DAUNORUBICIN?
Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAUNORUBICIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DAUNORUBICIN Cause?
Febrile neutropenia (1,311)
Pyrexia (645)
Neutropenia (631)
Sepsis (515)
Off label use (462)
Pneumonia (402)
Bacterial infection (400)
Drug ineffective (375)
Septic shock (363)
Thrombocytopenia (347)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which DAUNORUBICIN Alternatives Have Lower Hyperkeratosis Risk?
DAUNORUBICIN vs DAXIBOTULINUMTOXIN A-LANM
DAUNORUBICIN vs DAYTRANA
DAUNORUBICIN vs DECITABINE
DAUNORUBICIN vs DEFERASIROX
DAUNORUBICIN vs DEFERIPRONE